Hankyel Park

Array ( [id] => 1532119 [patent_doc_number] => 06410316 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Methods for producing a vector producing cell line utilizing a high multiplicity of transduction' [patent_app_type] => B1 [patent_app_number] => 09/526983 [patent_app_country] => US [patent_app_date] => 2000-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 17566 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410316.pdf [firstpage_image] =>[orig_patent_app_number] => 09526983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1567657 [patent_doc_number] => 06376658 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Proteins related to encapsulation and genes encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/521780 [patent_app_country] => US [patent_app_date] => 2000-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5314 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376658.pdf [firstpage_image] =>[orig_patent_app_number] => 09521780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1584974 [patent_doc_number] => 06358709 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'End selection in directed evolution' [patent_app_type] => B1 [patent_app_number] => 09/522289 [patent_app_country] => US [patent_app_date] => 2000-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 65132 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358709.pdf [firstpage_image] =>[orig_patent_app_number] => 09522289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1326348 [patent_doc_number] => 06599710 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'Treatment of autoimmune disease' [patent_app_type] => B1 [patent_app_number] => 09/521064 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 20 [patent_no_of_words] => 14571 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599710.pdf [firstpage_image] =>[orig_patent_app_number] => 09521064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265785 [patent_doc_number] => 06306648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Cyclin-C variants, and diagnostic and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/521144 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 33689 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306648.pdf [firstpage_image] =>[orig_patent_app_number] => 521144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517076 [patent_doc_number] => 06500663 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Unique associated Kaposi\'s sarcoma virus sequences and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/519489 [patent_app_country] => US [patent_app_date] => 2000-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 32098 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500663.pdf [firstpage_image] =>[orig_patent_app_number] => 09519489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268851 [patent_doc_number] => 06245563 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/516738 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7486 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245563.pdf [firstpage_image] =>[orig_patent_app_number] => 516738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284661 [patent_doc_number] => 06235263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Carboxy-terminal BRCA1 interacting protein' [patent_app_type] => 1 [patent_app_number] => 9/515884 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 22947 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235263.pdf [firstpage_image] =>[orig_patent_app_number] => 515884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355953 [patent_doc_number] => 06190887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein' [patent_app_type] => 1 [patent_app_number] => 9/514953 [patent_app_country] => US [patent_app_date] => 2000-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 38 [patent_no_of_words] => 27291 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190887.pdf [firstpage_image] =>[orig_patent_app_number] => 514953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1546447 [patent_doc_number] => 06444805 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Recombinant human papillomavirus vaccine expressed in transgenic plants' [patent_app_type] => B1 [patent_app_number] => 09/512569 [patent_app_country] => US [patent_app_date] => 2000-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 8639 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444805.pdf [firstpage_image] =>[orig_patent_app_number] => 09512569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477431 [patent_doc_number] => 06344337 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid' [patent_app_type] => B1 [patent_app_number] => 09/506630 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13645 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344337.pdf [firstpage_image] =>[orig_patent_app_number] => 09506630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209029 [patent_doc_number] => 06713279 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Non-stochastic generation of genetic vaccines and enzymes' [patent_app_type] => B1 [patent_app_number] => 09/498557 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 73 [patent_no_of_words] => 174433 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713279.pdf [firstpage_image] =>[orig_patent_app_number] => 09498557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1410580 [patent_doc_number] => 06524825 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins' [patent_app_type] => B1 [patent_app_number] => 09/498918 [patent_app_country] => US [patent_app_date] => 2000-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16365 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524825.pdf [firstpage_image] =>[orig_patent_app_number] => 09498918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4317692 [patent_doc_number] => 06248565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Immunization with plasmid encoding immunogenic proteins and intracellular targeting sequences' [patent_app_type] => 1 [patent_app_number] => 9/496301 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 18144 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248565.pdf [firstpage_image] =>[orig_patent_app_number] => 496301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527870 [patent_doc_number] => 06479258 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Non-stochastic generation of genetic vaccines' [patent_app_type] => B1 [patent_app_number] => 09/495052 [patent_app_country] => US [patent_app_date] => 2000-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 66 [patent_no_of_words] => 175651 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479258.pdf [firstpage_image] =>[orig_patent_app_number] => 09495052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320822 [patent_doc_number] => 06331404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'HIV envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/492739 [patent_app_country] => US [patent_app_date] => 2000-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 29929 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331404.pdf [firstpage_image] =>[orig_patent_app_number] => 492739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308522 [patent_doc_number] => 06316211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'ThdF' [patent_app_type] => 1 [patent_app_number] => 9/491785 [patent_app_country] => US [patent_app_date] => 2000-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14765 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316211.pdf [firstpage_image] =>[orig_patent_app_number] => 491785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284638 [patent_doc_number] => 06268126 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Antiviral polymers comprising acid functional groups and hydrophobic groups' [patent_app_type] => 1 [patent_app_number] => 9/491008 [patent_app_country] => US [patent_app_date] => 2000-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4142 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268126.pdf [firstpage_image] =>[orig_patent_app_number] => 491008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257875 [patent_doc_number] => 06258599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Compositions and methods for treating viral infections' [patent_app_type] => 1 [patent_app_number] => 9/482612 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27747 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258599.pdf [firstpage_image] =>[orig_patent_app_number] => 482612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4341756 [patent_doc_number] => 06284456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Transcriptional coactivator that interacts with Tat protein and regulates its binding to TAR RNA, methods for modulating Tat transactivation, and uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/476482 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26009 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284456.pdf [firstpage_image] =>[orig_patent_app_number] => 476482 [rel_patent_id] =>[rel_patent_doc_number] =>)